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Abstract
Background: The objective of this case report is to describe the clinical presentation of a patient
who complained of shoulder pain and was diagnosed with carcinoma of the scapula and spine that
metastasized from the lung.
Case presentation: A 76-year-old man without a history of cancer sought chiropractic care for
right shoulder pain. Careful evaluation, radiographs, and subsequent imaging revealed primary and
metastatic lung cancer. The patient was referred to his primary care physician for immediate
medical care. Diagnostic images are included in this case to provide a comprehensive depiction of
the scope of the patient's disease.
Conclusion: Musculoskeletal symptoms are commonly encountered in chiropractic practice. It is
important to recognize that primary lung cancer may be unidentified, and musculoskeletal
symptoms may reflect the first sign of primary or metastatic pulmonary disease. Thoughtful
evaluative procedure and clinical decision making, combined with the use of appropriate diagnostic
tests may allow timely identification of primary or metastatic disease.
Background
In the USA, more people die from lung cancer than any
other type of cancer [1]. This is true for both men and
women. In 2004, lung cancer accounted for more deaths
than breast cancer, prostate cancer, and colon cancer com-
bined [2].
Lung cancer can metastasize to virtually any bone, although
the axial skeleton and proximal long bones are most com-
monly involved [3]. The primary symptom resulting from
bone involvement is pain, which may have a pleuritic com-
ponent when the ribs are involved. Bone pain is present in
up to 25% of all patients at presentation [3].
Patients commonly seek chiropractic care with muscu-
loskeletal complaints [4,5]. Through history and exami-
nation, chiropractic physicians have an opportunity to
assess patients and determine whether serious conditions
are present that may necessitate medical referrals.
Patients with previously identified or yet to be identified
cancer may seek care with chiropractic physicians. This
case report demonstrates previously undiagnosed lung
cancer with widespread metastatic foci.
Case presentation
Case report
A 76-year-old male sought chiropractic care for com-
plaints of right shoulder pain and mild right arm weak-
ness. The onset of pain was insidious and of one week's
duration. Pain was rated 8/10 on a visual analogue scale
(0 = no pain, 10 = the worst pain of one's life). The pain
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was described as severe and worsened with movement.
Additional symptoms included mild shortness of breath
and posterior thoracic pain on respiration.
The patient's past medical history included headache,
degenerative joint disease affecting the cervical spine, and
a benign thyroid nodule. The patient reportedly smoked
tobacco products for 50 years. He was a retired electrician.
The patient was afebrile. Vital signs were normal. Respira-
tions were 18 cycles per minute. The lungs were clear to
auscultation. The patient reported upper thoracic pain on
inspiration.
A non-tender, mild decrease in active range of motion of
the cervical spine was noted in all planes. No tenderness
was elicited on palpation of the cervical spine. Cervical
compression and Soto-Hall tests were negative. Valsalva
maneuver was negative. Neurologic examination revealed
no focal deficits.
Examination of the right shoulder revealed exquisite ten-
derness on palpation of the lateral border of the scapula
with muscle spasm affecting the ipsilateral infraspinatus,
teres major, and teres minor muscles. Active ranges of
shoulder motion were restricted and painful in abduction,
internal, and external rotation.
Plain film radiographs of the right shoulder (AP with
internal and external rotation views) and thoracic spine
(AP and lateral views) were performed. Disruption of the
cortical margin of the lateral border of the right scapula
was noted as evidenced by an indistinct lucency (see Fig-
ure 1). In addition, a suspicious mass was noted in the
hilar region of the right lung. Complete loss of the right
hilar vascular detail secondary to the tumor mass effect
were noted with visualized subsegmental infiltrate densi-
ties. No evidence of pleural effusion was noted.
The initial diagnostic impression included: suspicious
right lung pathology and apparent lytic process affecting
the scapula of an unknown origin. The patient was
referred for imaging evaluations that included chest x-ray
(CXR) and computed tomographic (CT) evaluation of the
chest. He was referred to his primary care medical physi-
cian.
The CXR and CT examination of the chest, abdomen and
pelvis revealed:
1. A large mass in the right upper lobe of the lung with
associated mediastinal and hilar adenopathy (see Figures
2 and 3).
2. Metastatic disease of the scapula (see Figure 4).
3. Metastatic liver disease.
Subsequent bone scintigraphy revealed abnormal
increased accumulation of radiopharmaceutical along the
lateral aspect of the right scapula (see Figure 5). MRI eval-
uation revealed additional metastatic foci including the
cervical, thoracic and lumbar spinal regions as evidenced
by multiple regions of decreased signal intensity are visu-
alized on T1 weighted images (see Figures 6 and 7).
AP radiograph of the right scapula reveals a focal indistinct  lucency and lytic destruction of the lateral scapular cortical  margin Figure 1
AP radiograph of the right scapula reveals a focal 
indistinct lucency and lytic destruction of the lateral 
scapular cortical margin.
PA chest radiograph reveals a right hilar mass Figure 2
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Biopsy confirmed a primary lung carcinoma origin.
Unfortunately, the patient succumbed to the disease
within 3 months of its diagnosis.
Discussion
Chiropractic considerations
The identification of primary or secondary metastatic can-
cer requires careful consideration with regard to history
and physical examination. A key objective for the chiro-
practic physician is to identify "red flags" as quickly as
possible. This is especially true for any disease process that
may weaken bone.
The application of directed force into spinal or osseous
structures inherent to the chiropractic adjustment man-
date careful evaluative procedure. Janse defined the
adjustment as a specific form of articular manipulation
using long or short lever techniques with specific contacts
and is characterized by a dynamic thrust of controlled
velocity, amplitude and direction [6].
While chiropractic physicians are challenged with the
responsibility of attempting to identify relative and abso-
lute contraindications to spinal adjustments, sometimes
early onset, insidious and seemingly innocuous symp-
toms may delay early identification [7,8].
Clinical considerations
When primary cancer is not yet identified, metastatic
extension to skeletal structures can at times be difficult to
detect [7,8]. As was illustrated in this case, clinical consid-
erations that may assist or delay the identification of met-
astatic bone disease include:
1. Early in the course of the disease progression, impor-
tant red flag identifiers may not initially be present and
can delay early identification.
2. Initial pain presentations may be suggestive of com-
mon clinical conditions that are less aggressive.
3. Patients may or not be aware of, or report, the existence
of a primary cancer.
4. Pain can be initially mild to severe and is often progres-
sive in nature and unremitting despite therapeutic inter-
ventions.
5. It is sometimes extremely difficult to positively identify
metastatic disease due to complex clinical factors [7,8].
Red flag indicators for metastatic bone disease include:
age over 50 or under 20 years, a history of cancer, consti-
tutional symptoms including unexplained weight loss,
CT of the chest reveals a large mass in the right upper lobe  of the lung with associated mediastinal and hilar adenopathy Figure 3
CT of the chest reveals a large mass in the right 
upper lobe of the lung with associated mediastinal 
and hilar adenopathy.
CT of the chest reveals cortical lucency, expansile destruc- tion, and medullary invasion due to metastatic lung carci- noma affecting the right scapula Figure 4
CT of the chest reveals cortical lucency, expansile 
destruction, and medullary invasion due to meta-
static lung carcinoma affecting the right scapula.Chiropractic & Osteopathy 2008, 16:8 http://www.chiroandosteo.com/content/16/1/8
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pain worse at night or in atypical areas, no significant
improvement after > 1 month of conservative (non-inva-
sive) care, pain that has no mechanical exacerbating or
remitting factors, and severe disabling pain affecting a
child or adolescent [9].
Diagnostic imaging considerations
Humphrey reported that about 25% of people with lung
cancer do not have symptoms from advanced cancer
when their lung cancer is found [10]. Maghfoor reported
that 7–10% of patients with lung cancer are asymptomatic
and their cancers are diagnosed incidentally after a CXR
was performed for other reasons [11]. Numerous studies
have shown that the chest radiograph lacks sensitivity in
detecting mediastinal lymph node metastases and in
detecting chest wall and mediastinal invasion [12].
CT has become the major imaging modality of choice in
the evaluation of patients with bronchogenic carcinoma
[13]. Traditionally, chest CT for staging of lung cancer is
extended into the abdomen to include the adrenal glands.
Whether this requires intravenous contrast material is
debatable [13]. Patz et al. [14] concluded that contrast-
enhanced CT extended to include the liver rarely adds to
Bone scintigraphy of the right scapula reveals increased  uptake where metastatic lung carcinoma is present Figure 5
Bone scintigraphy of the right scapula reveals 
increased uptake where metastatic lung carcinoma is 
present.
MRI sagittal T1WI reveals scattered foci of decreased signal  intensity reflective of metastatic disease affecting the cervical  and thoracic spine regions Figure 6
MRI sagittal T1WI reveals scattered foci of 
decreased signal intensity reflective of metastatic dis-
ease affecting the cervical and thoracic spine regions.
MRI sagittal T1WI reveals scattered foci of decreased signal  intensity reflective of metastatic disease affecting the tho- raco-lumbar spine Figure 7
MRI sagittal T1WI reveals scattered foci of 
decreased signal intensity reflective of metastatic dis-
ease affecting the thoraco-lumbar spine.Chiropractic & Osteopathy 2008, 16:8 http://www.chiroandosteo.com/content/16/1/8
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routine nonenhanced CT through the adrenal glands and
does not influence management decisions.
The evaluation of the mediastinum with magnetic reso-
nance imaging (MRI) is approximately equal to that of CT
with regard to the staging of bronchogenic carcinoma and
MRI is significantly more accurate for detecting direct
mediastinal invasion [15]. Other studies have confirmed
the usefulness of MRI, particularly in the evaluation of
chest wall invasion and the local staging of superior sulcus
tumors [16,17]. The general conclusion of these studies is
that MRI has advantages in the assessment of both chest
wall and mediastinal invasion [13].
Indications for the use of whole body positron emission
tomography imaging in lung cancer using 18-fluorodeox-
yglucose (FDG-PET) in patients with non-small cell lung
cancer include high clinical index of suspicion of high
grade malignancy and radiographic evidence of nodal
enlargement [13]. In addition, PET scans may be helpful
in centers where mediastinoscopy is not readily available
and in patients with significant comorbid conditions who
are borderline candidates for surgery, with locally
advanced disease, solitary brain metastasis, and cases of
local recurrence that might qualify for reoperation
[18,19].
Bone scintigraphy in the detection of metastatic disease
has significant limitations. Although it has high sensitiv-
ity, it is noted for having very low specificity that ranges
from 50%–60% [13]. Bone scintigraphy should probably
be limited to cases in which patients have specified clini-
cal indicators of bone metastasis [20].
When evaluating suspected pulmonary metastasis, CXR
and CT of the chest are rated by the American College of
Radiology (ACR) scale as: "9 – most appropriate" (Rating
Scale: 1-Least appropriate, 9-Most appropriate) [21]. It is
generally accepted that chest radiography, with poster-
oanterior (PA) and lateral views, should be the initial
imaging test in patients without known or suspected tho-
racic metastatic disease [22-24]. Compared with chest
radiography, CT is much more sensitive for detecting pul-
monary nodules, because of its lack of superimposition
and its high contrast resolution [22-24].
Conclusion
Lung cancer is a significant and aggressive primary cancer
with a predilection for skeletal metastasis. When primary
lung cancer is not previously identified, metastatic disease
to skeletal structures may initially manifest as muscu-
loskeletal complaints. Careful diagnostic evaluation and
decision making may allow for earlier diagnosis.
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